A Study of Nilotinib Versus Imatinib in GIST Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This study will evaluate efficacy and safety of nilotinib versus imatinib in adult patients with unresectable or metastatic gastrointestinal stromal tumors (GIST).
Epistemonikos ID: 4c1ca70638f55d7fcf7a38817b8cd2c14b7afa24
First added on: May 05, 2024